Cost-Effectiveness Analysis of rFVIIIFc Versus Contemporary rFVIII Treatments for Patients with Severe Hemophilia A Without Inhibitors in the United States
2017 ◽
Vol 28
(4)
◽
pp. 1578-1597
◽
2018 ◽
Vol 38
(5)
◽
pp. 520-530
◽